Atezolizumab plus Bevacizumab Clinical Trials
2 recruitingDrug
Not Applicable1Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
HCC
Chinese University of Hong Kong40 enrolled2 locationsNCT06823375
Recruiting
Not Applicable
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
Hepatocellular CarcinomaTumor ThrombusHepatic Portal Vein Tumor Invasion
Third Affiliated Hospital, Sun Yat-Sen University234 enrolled1 locationNCT05984511